Core Catalyst Pilot Award
Forecasted
Core Catalyst Pilot Award supports Columbia faculty using core facilities to analyze existing biospecimens for innovative pre-clinical and clinical research that could advance patient care and health.
This grant was recently updated
The application cycle is now closed, replacing the previously listed October 13, 2026 deadline.
Funder: Columbia University Irving Medical Center
Due Dates (Anticipated): October 2027 (Application deadline)
Funding Amounts: $50,000 per award
Summary: Supports Columbia faculty using CUIMC core facilities to analyze existing biospecimens for innovative pre-clinical and clinical research.
Key Information: Principal investigators must hold a Columbia University faculty appointment at assistant professor rank or higher.
Description
The Core Catalyst Pilot Award is provided through the Irving Institute’s Pilot Program at Columbia University Irving Medical Center (CUIMC). It rapidly deploys funding for the use of CUIMC core facilities in translational science, particularly clinical research. Projects address innovative pre-clinical or clinical questions through analysis of previously collected biospecimens.
Research may involve cellular and molecular analyses across the translational spectrum, from pre-clinical studies to clinical trials. Investigators can collaborate with institutional or departmental cores, including the Irving Institute’s Biomarkers Core Laboratory. Individual cores or combinations of facilities can provide end-to-end sample analysis, including for investigators without dedicated laboratory resources. The program seeks data that could support future funding and ultimately advance patient care and health.
